External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology ESMO Asia 2025
Roche and Genentech at

ESMO Asia 2025

December 05 - December 07
Singapore, Republic of Singapore
www.esmo.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
03:30 AM
Duration 5mins Singapore
Lurbinectedin + atezolizumab as first-line maintenance treatment in patients with extensive-stage small-cell lung cancer (ES-SCLC): IMforte Asia subgroup results
Yaewon Yang, Ki Hyeong Lee, Martin Reck, Hossein Borghaei, Stephen V. Liu, Solange Peters, Roy S. Herbst, Young Joo Min, Se Hyun Kim, Chi-Lu Chiang, Tsung-Ying Yang, Vaikunth Cuchelkar, Vilma Graupner, Ya-Chen Lin, Debasis Chakrabarti, Kamalnayan Bhatt, Luis Paz-Ares
Oncology | Small Cell Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.